Marshall Wace, LLP Insmed Inc Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Insmed Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 1,064,215 shares of INSM stock, worth $77.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,064,215
Previous 771,211
37.99%
Holding current value
$77.3 Million
Previous $56.3 Million
30.51%
% of portfolio
0.09%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding INSM
# of Institutions
501Shares Held
188MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$942 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$923 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$517 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.84B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...